Clinical trials: design, endpoints and interpretation of outcomes
Author:
Funder
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Link
https://www.nature.com/articles/s41409-021-01542-0.pdf
Reference46 articles.
1. Zheng C, Dai R, Gale R, Zhang M. Causal inference in randomized clinical trials. Bone Marrow Transpl. 2019;55:4–8.
2. Jabbour J, Manana B, Zahreddine A, Al-Shaar L, Bazarbachi A, Blaise D, et al. Vitamins and minerals intake adequacy in hematopoietic stem cell transplant: results of a randomized controlled trial. Bone Marrow Transpl. 2021;56:1106–15.
3. Kantarjian HM, DeAngelo DJ, Stelljes M, Martinelli G, Liedtke M, Stock W, et al. Inotuzumab ozogamicin versus standard therapy for acute lymphoblastic leukemia. N Engl J Med. 2016;375:740–53.
4. DiNardo CD, Jonas BA, Pullarkat V, Thirman MJ, Garcia JS, Wei AH, et al. Azacitidine and venetoclax in previously untreated acute myeloid leukemia. N Engl J Med. 2020;383:617–29.
5. Kantarjian H, Stein A, Gökbuget N, Fielding AK, Schuh AC, Ribera J-M, et al. Blinatumomab versus chemotherapy for advanced acute lymphoblastic leukemia. N Engl J Med. 2017;376:836–47.
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Strategic Management for Innovation in Life Sciences: A Comprehensive Overview;Management for Professionals;2024
2. When observation meets randomization: ‘Don't let a crisis go to waste’;European Journal of Heart Failure;2023-11-21
3. Endpoint selection and evaluation in hematology studies;Best Practice & Research Clinical Haematology;2023-09
4. Foundations for improved vaccine correlate of risk analysis using positive-unlabeled learning;Human Vaccines & Immunotherapeutics;2023-01-02
5. Research Question, Objectives, and Endpoints in Clinical and Oncological Research: A Comprehensive Review;Cureus;2022-09-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3